EMOVATE crème tb 30 g

7680431420016 CH-43142 D07AB01 10.05.1.
EMOVATE crème tb 30 g
EMOVATE crème tb 30 g
EMOVATE crème tb 30 g
1 / 3
google

Details

Product number
4314201
CPT
-
Packaging group
30
Unit
g
Composition
clobetasoni-17 butyras 0.5 mg, glyceroli monostearas 40-55, alcohol cetylicus et stearylicus 48 mg, apis cera synthetica, glyceroli monostearas, macrogoli 5000 monostearas, dimeticonum 20, glycerolum, chlorocresolum 1 mg, acidum citricum, acidum citricum monohydricum, aqua purificata, ad unguentum pro 1 g.

Articles (1)

Emovate, Crème
Crème
30
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
27/06/2025
Patient information leaflet
Français
27/06/2025
Patient information leaflet
Italien
27/06/2025
Professional SmPC
Allemand
27/06/2025
Professional SmPC
Français
27/06/2025
Professional SmPC
Italien
27/06/2025

Detailed composition

Substance Quantity Type Category
(N/A)
0.5 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
48.0 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
1.0 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 12.60
Specialties list
Yes
Generic
No
SL addition date: 01/04/2016

Authorization holder

GlaxoSmithKline AG

6340 Baar

Authorization information

Swissmedic authorization number
43142
Drug name
Emovate, Crème
Galenic form
CREM
ATC Code
D07AB01
Authorization status
Z
Dispensation category
B
First authorization
25/08/1980
Authorization expiration date
31/12/9999
IT number
10.05.1.
Domain
Human medicine
Field of application
Entzündliche, nicht infizierte Dermatosen

Packaging details

Description (FR)
EMOVATE crème tb 30 g
Description (DE)
EMOVATE Creme Tb 30 g
Market launch
25/08/1980
Narcotic (BTM)
No

Other packaging sizes